Evidence map›Paper›PMID 30699959›Full record

ReviewViruses2019

Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism.

Philip T Lange, Michael Lagunoff, Vera L Tarakanova

Abstract readReview
In one paragraph

Review in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philip T LangeDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. plange@mcw.edu.
Michael LagunoffDepartment of Microbiology, University of Washington, Seattle, WA 98101, USA. lagunoff@uw.edu.
Vera L TarakanovaDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. vera@mcw.edu.

Funding

KSHV alteration of cellular metabolismR01CA189986 · NCI · UNIVERSITY OF WASHINGTON · PI LAGUNOFF, MICHAEL · 2015 to 2024
$3.7M
Interactions of KSHV and endothelial cellsR01CA097934 · NCI · UNIVERSITY OF WASHINGTON · PI LAGUNOFF, MICHAEL · 2003 to 2012
$2.7M
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesisR01CA203923 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI TARAKANOVA, VERA L. · 2017 to 2021
$2.0M
ATM and gammaherpesvirus infection: a precarious balanceR01CA183593 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI TARAKANOVA, VERA L. · 2014 to 2018
$1.6M
NCI NIH HHS R01 CA097934NCI NIH HHS R01 CA183593NCI NIH HHS R01 CA189986NCI NIH HHS R01 CA203923NIH HHS CA183593NIH HHS CA203923NIH HHS CA217788
6 · The paper itself

Abstract

Viruses manipulate numerous host factors and cellular pathways to facilitate the replication of viral genomes and the production of infectious progeny. One way in which viruses interact with cells is through the utilization and exploitation of the host lipid metabolism. While it is likely that most-if not all-viruses require lipids or intermediates of lipid synthesis to replicate, many viruses also actively induce lipid metabolic pathways to sustain a favorable replication environment. From the formation of membranous replication compartments, to the generation of ATP or protein modifications, viruses exhibit differing requirements for host lipids. Thus, while the exploitation of lipid metabolism is a common replication strategy, diverse viruses employ a plethora of mechanisms to co-opt these critical cellular pathways. Here, we review recent literature regarding the exploitation of host lipids and lipid metabolism specifically by DNA viruses. Importantly, furthering the understanding of the viral requirements for host lipids may offer new targets for antiviral therapeutics and provide opportunities to repurpose the numerous FDA-approved compounds targeting lipid metabolic pathways as antiviral agents.

Indexed as

Host Microbial InteractionsLipid MetabolismAnimalsDNA VirusesGenome, ViralHumansMetabolic Networks and PathwaysMiceRhadinovirusVirus ReplicationcholesterolDNA virusfatty acidsherpesviruslipidsMHV68

Identifiers

PMID30699959
PMCPMC6409581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.